Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Communication
Treatment
Care Practice
Prevention
View all Topics
Conferences
CTAD 2022
AAIC 2022
EAN 2022
ESOC 2022
AAN 2022
CONy 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Alzheimer’s Disease
3:55
Highlights from CTAD 2022
Jacques Touchon
• 9 Dec 2022
1:50
Prioritizing the mechanistic understanding of AD to improve treatments
Jared Roach
• 22 Nov 2022
2:53
Photobiomodulation: why target the brain and the gut?
Jacques Touchon
• 9 Dec 2022
9:01
Longitudinal clinical outcomes of tau-PET-positive individuals
Alexis Moscoso Rial
• 15 Dec 2022
3:11
Clinical implementations of AlzoSure Predict
Paul Kinnon
• 28 Nov 2022
1:35
Predicting tau-PET signal in early Alzheimer’s disease using speech biomarkers
Nicklas Linz
• 8 Dec 2022
3:12
APOE-targeted epigenome therapy for Alzheimer’s disease
Ornit Chiba-Falek
• 6 Dec 2022
5:48
Meta-analysis of the latest anti-amyloid immunotherapies: benefit vs risk
Nicolas Villain
• 6 Dec 2022
6:37
Blood-based biomarkers as surrogates of amyloid burden in preclinical Alzheimer’s disease
Charisse Winston
• 2 Dec 2022
3:10
Promise of exosomal proteins as biomarkers in Alzheimer’s disease
Charisse Winston
• 2 Dec 2022
1:29
Limitations of [18F]flortaucipir tau-PET imaging
Alexis Moscoso Rial
• 15 Dec 2022
13:27
First-in-human clinical trial of the anti-PD-L1 antibody, IBC-Ab002, in early AD
Jesse Cedarbaum
• 1 Dec 2022
2:24
Lecanemab and what this means for the future treatment of Alzheimer’s disease
Jesse Cedarbaum
• 1 Dec 2022
2:52
Speech biomarker for cognition: a novel marker for AD clinical trial screening
Nicklas Linz
• 8 Dec 2022
1:13
Ensuring the safety of epigenome therapies in the treatment of Alzheimer’s disease
Ornit Chiba-Falek
• 6 Dec 2022
5:40
Future direction for anti-amyloid immunotherapies
Nicolas Villain
• 6 Dec 2022
Previous
1
2
3
4
5
6
…
47
Next